AVOIDING DECEPTIVE IMPRINTING OF THE IMMUNE RESPONSE TO HIV-1 INFECTION IN VACCINE DEVELOPMENT

REFERENCES

• T., Francis, Jr.. Influenza New aquaintenance. Ann. Intern. Med.. 39: 203–221, 1953
   PubMed Web of Science ®Google Scholar
• A., Amadori, R., Zamarchi, V., Ciminale, A. Del, Mistro, S., Siervo, A., Alberti, M., Colombatti, L., Chieco-Bianchi. HIV-1-specific B cell activation: A major constituent of spontaneous B cell activation during HIV-1 infection. J. Immunol.. 143: 2146–2152, 1989
   PubMedGoogle Scholar
• L. M.E., Grimaldi, R. P., Roos, S. G., DeVar, W. G., Robey, J. M., Casey, M. E., Geerney, Apatoff B. R., A., Lazzarins. Restricted heterogeneity of antibody to gp120 and p24 in AIDS. J. Immunol.. 141: 114–117, 1988, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• S., Müller, H., Wang, G. J., Silverman, G., Bramlet, N., Haigwood, H., Kohler. B-cell abnormalities in AIDS:Stable and clonally-restricted antibody response in HIV-1 infection. Scand. J. Immunol.. 38: 327–334, 1993
   PubMedGoogle Scholar
• S., Müller, P. L., Nara, R., D'Amelio, R., Biselli, D., Gold, H., Wang, H., Kohler, Silverman G. J.. Clonal patterns in the human immune response to HIV-1 infection. Internat. Rev. of Immunol.. 9: 1–13, 1992
   PubMedGoogle Scholar
• R. R., D'Amelio, R., Biselli, P. M., Nisini, A., Matricardi, I., Aiuti, E., Mezzaroma, O., Pinter, N., Pontesilli, F., Aiuti. Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J. Acquir. Immune Defic. Syndr.. 5: 930–935, 1992
   PubMedGoogle Scholar
• P., Nara, M., Merges, R., Garrity, S., Con, A., Minassian, W. P., Tsai, G., Rimmelswaan, J., Goudsmit, S., Müller, H. T., Wang, H., Köhler. Modern Approaches to New Vaccines. Cold Spring Harbar, Ny, Cold Spring Harbor Laboratory Press. 1993, Vaccine 93, pp. 167–175
   Google Scholar
• H., Köhler, J., Goudsmit, P., Nara. Clonal dominance: Cause of a limited and failing immune response to HIV-1 infection and vaccination. J. AIDS. 5: 1158–1168, 1992
   PubMedGoogle Scholar
• H., Köhler, P. L., Nara, S., Müller. Deceptive imprinting in the immune response against HIV-1. Immunol. Today. 15: 475–478, 1994, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• P. L., Nara, R., Garrity. Deceptive Imprinting: A cosmopolitan strategy for complicating vaccination. Vaccine. 16: 1780–1787, 1998, [CSA], [CROSSREF]
   Google Scholar
• H., Kohler, S., Muller, P. L., Nara. Why AIDS vaccines that induce humoral immunity may not work. The Immunologist. 3: 32–34, 1995, [CSA]
   Google Scholar
• A. J., McMichaels, R. E., Philips. Escape of human immunodeficiency virus from immune control. Ann. Rev. Immunol.. 15: 271–296, 1997, [CSA], [CROSSREF]
   Google Scholar
• Z. W., Chen, Y., Shen, Z., Kou, C., Ibegbu, D., Zhou, L., Shen, P., Morrison, C., Bogle, H. M., McClure, A. J., Nahmias, P. K., Sehgal, N. L., Letvin. Prolonged dominance of restricted CD4(+) T cells in macaques infected with simian immunodeficiency virus. J. Virol.. 74: 7442–7450, 2000, [CSA], [CROSSREF]
   Google Scholar
• L., Berberian, L., Goodglick, T. J., Kipps, J. A., Braun. Immunoglobulin VH3 gene products; Natural ligands for HIV gp20. J. Science. 261: 1588–1591, 1993
   PubMed Web of Science ®Google Scholar
• L., Berberian, J., Shukla, R., Jefferis, J., Braun. Effects of HIV Infection on VH3 (D12 Idiotope) B Cells In Vivo. J. AIDS. 7: 641–646, 1994
   PubMedGoogle Scholar
• S., Muller, H.-T., Wang, S.-V., Kaveri, S., Chattopadhyay, H., Kohler. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-1 specific antibodies. J. Immunol.. 147: 933–941, 1991
   PubMedGoogle Scholar
• H. T., Wang, S., Muller, S., Zolla-Pazner, H., Kohler. Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity. Eur. J. Immunol.. 22: 1749–1755, 1992, [CSA]
   PubMedGoogle Scholar
• S., Muller, H., Kohler. B cell superantigens in HIV-1 infection. Intern. Rev. Immunol.. 14: 339–349, 1997, [CSA]
   PubMedGoogle Scholar
• V., Veljkovic, R., Metlas, H., Kohler. et al.. AIDS epidemic at the beginning of the new millenium: Time for a new AIDS strategy. JVAC. 19: 1855–1862, 2001, [CSA]
   Google Scholar
• C. P., Locher, R. M., Grant, E. A., Collisson, G., Reyes-Teran, T., Elbeik, J. O., Kahn, J. A., Levy. Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination. AIDS Res. Hum. Retrovir.. 71: 1685–1659, 1999
   Google Scholar
• L., Berberian, Y., Valles-Ayoub, N., Sun, O. Martinez, Maza, J., Braun. A VH clonal deficit in human immunodeficiency virus-positive individuals reflect a B-cell maturational arrest. Blood. 78: 175–179, 1991
   PubMed Web of Science ®Google Scholar
• M., Saitta, A., Iavarone, N., Cappello, M. R., Bergami, G. C., Fiorucci, F., Aguzzi. Reference alues for immunoglobulin kappa and lambda light-chains and the kappa/lambda ratio in children's serum. Clin. Clem.. 38(12)2454–2457, 1992
   Google Scholar
• A. H., Lucas, F. H., Azmi, C. M., Mink, D. M., Granoff. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J. Immunol.. 150: 2056–2061, 1993
   Google Scholar
• Q., Wang, P.-A., Tovo, H., Kohler, S., Pahwa, S., Muller. Restriction of clonal heterogeineity and maternal imprinting of B cells in the baby's immune response against HIV-1. Abstract 1209. Human immunodeficiency virus and animal model FASEB J.. Abstracts, part I, Experimental Biology Meeting. Atlanta, GA, 9–13, April, 1995
   Google Scholar
• Center for Disease Control(CDC). Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 43: 1–10, 1994
   Google Scholar
• M., Saitta, F., Gaido, E., Palombo, P., Cirino, A., Giaccone, E., Ciuti, P. A., Tovo. Reduced immunoglobulin Kappa/lambda light chain ratio in perinatally HIV-1 infected children. Ped. AIDS HIV Infect., Fetus to Adolescent. 5: 344–349, 1994
   Google Scholar
• Y. J., Bryson, S., Pang, L. S., Wei, R., Dickover, A., Diagne, I. S.Y., Chen. Clearance of HIV Infection in a Perinatally Infected Infant. New Eng. J. Med.. 332(13)833–838, 1995, [CSA], [CROSSREF]
   Google Scholar
• H., Pollack, M. X., Zhan, T., Ilmet-Moore, K., Ajuang-Siimbiri, K., Krasinski, W., Borkowsky. Ontogeny of anti-human Immunodeficiency virus (HIV) antibody production in HIV-1-infected infants. Proc. Nat. Acad. Sci.. 90: 2340–2344, 1993
   PubMed Web of Science ®Google Scholar
• M., Wikler, C., Demeur, G., Dewasme, J., Urbain. Immunoregulatory role of matrnal idiotopes. Ontogeny of immune networks. J. Exp. Med.. 152: 1024–1035, 1980, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., Salk, P. A., Bretscher, P. L., Salk, M., Clerici, G. M., Shearer. Strategy for Prophylactic Vaccination against HIV. Science. 260: 1270–1272, 1993
   PubMedGoogle Scholar
• D. H., Barouch, S., Santra, J. E., Schmitz, M. J., Kuroda, T.-M., Fu, W., Wagner, M., Bilska, A., Craiu, X. X., Zheng, G. R., Krivulka, K., Beaudry, M. A., Lifton, C. E., Nickerson, W. L., Trigona, K., Punt, D. C., Freed, L., Guan, S., Dubey, D., Casimiro, W. P., Tsai, G., Lin, J. J., de Jong, J., Goudsmit, M., Chastain, T. B., Strom, R. S., Gelman, P. L., Nana, A., Simon, M.-E., Davies, D. C., Montefiori, M. G., Lewis, E. A., Emini, J. W., Shiver, N. L., Letvin. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290: 486–492, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H., Kohler. Superantibodies.. Synergy of Innate and Aquired Immunity. Appln. Biochem. Biotechnol.. 83: 1–12, 2000, [CROSSREF]
   Google Scholar
• R. R., Garrity, G., Rimmelzwaan, A., Minassian. Refocusing neutralizing antibody response by targeted dampening of an immunodomiant epitope. J. Immunol.. 159: 279–289, 1997
   PubMed Web of Science ®Google Scholar
• M., Agadjananyan, L. M. A., Ping, J., Westerink, T., Kicbert-Emmous. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nature Biotechnol.. 15: 547–551, 1997, [CSA], [CROSSREF]
   Google Scholar
• J. A., Levy. What can be achieved with an HIV vaccine?. Lancet. 357: 223–224, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. F., Zagury, A., Sill, W., Blattner. et al.. Antibodies to HIV-1 tat protein correlated with nonprogression to AIDS: A rationale for the use of tat toxoid as an HIV-1 vaccine. J. Hum. Virol.. 1: 282–292, 1998, [CSA]
   PubMedGoogle Scholar
• C. D., Pauza, P., Trivedi, M., Wallace. et al.. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Nat. Acad. Sci. USA. 97: 3515–3519, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Gringeri, E., Santagostino, M., Muca-Perja. et al.. Safety and immunogenicity of HIV-1 tat toxoid in immunocompromised HIV-infected patients. J. Hum. Virol.. 1: 293–298, 1998, [CSA]
   PubMedGoogle Scholar
• H., Kohler, M., Bhattacharya-Chatterjee, S., Muller, K., Foon. Idiotype manipulation in disease management, In. Immunobiology of Proteins and Peptides VIII, M. Z., Atassi, G. S., Bixler, Jr., New York, Plenum Press. 1995; pp. 117–122
   Google Scholar
• S., Muller, D. H., Margolin, P. L., Nara, W. G., Alvord, H., Kohler. Stimulation of HIV-1- neutralizing antibodies in simian HIV-IIIB-infected macaques. Proc. Nat. Acad. Sci. USA. 95: 276–281, 1998, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• C. Y., Wang, L. S. W., Swayer, K. K., Murthy. et al.,. Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc. Nat. Acad. Sci. USA. 96: 10367–10372, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T. C., Chan, G. R., Dreesman, R. C., Kennedy. Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc. Nat. Acad. Sci. USA. 84: 3891–3895, 1987, [CSA]
   Google Scholar
• E. M., Zhou, T. C., Chanh, G. R., Dreesman, P., Kanda, R. C., Kennedy. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induced an anti-gp160 response specific for a synthetic peptide, J. Immunol.. 139: 2959–2966, 1987
   Google Scholar
• A. G., Dagleish, B. J., Thomson, T. C., Chanh, M., Malkovsky, R. C., Kennedy. Neutralization of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: A potential AIDS vaccine. Lancet. 2: 1047–1050, 1987, [CROSSREF]
   Google Scholar
• R., Attanasio, R. C., Kennedy, J. S., Allan, V. C., Maino, P., Kanda. Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype. Mol. Immunol.. 6: 513–522, 1990
   Google Scholar
• R., Attanasio, J. S., Allan, S. A., Anderson, T. C., Chanh, R. C., Kennedy. Anti-idiotype antibody response to monoclonal anti-CD4 preparations in non human primates. J. Immunol.. 146: 507–514, 1991
   Google Scholar
• M. H., Shearer, D. K., Timanus, P. A., Benton, D. R., Lee, R. C., Kennedy. Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4. J. Infec. Dis.. 177: 1727–1729, 1998
   PubMed Web of Science ®Google Scholar
• M. H., Shearer, A. G., Dalgleish, T. C., Chanh, R. C., Kennedy. Idiotype cascade associated with the CD4-HIV glycoprotein 120 interaction: Immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity. AIDS Res. Hum. Retrovir.. 16: 77–86, 2000, [CSA], [CROSSREF]
   Google Scholar
• E. M., Zhou, K. L., Lohman, R. C., Kennedy. Administration of noninternal image monoclonal anti-idiotypic induces idiotype restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. Virology. 174: 9–17, 1990, [CSA], [CROSSREF]
   Google Scholar
• K. L., Lohman, M. A., Carillo, R. C., Kennedy. Sequence analysis of the variable region of a mouse gene encoding a monoclonal anti-idiotypic antibody that detects a restricted idiotype on anti-HIV-1 gp160. Gene. 105: 283–284, 1991, [CROSSREF]
   Google Scholar
• C. Y., Kang, P., Nara, S., Chamat, V., Caralli, A., Chen, M. L., Nguyen, H., Yoshiyama, W. J. W., Morrow, D. D., Ho, H., Kohler. Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys. Proc. Nat. Acad. Sci. USA. 89: 2546–2550, 1992, [CSA]
   PubMedGoogle Scholar
• S., Kaveri, T., Kieber-Emmons, W. J. W., Morrow, S., Muller, S., Raychaudhuri, H., Kohler. Idiotypic networks and nature of molecular mimicry: An overview,, In. Methods in Enzymology; vol. 178, Antibodies, Antigens, and Molecular Mimicry, John J., Langone. Academic Press, San Diego, CA 1989; pp. 3–35, Chap. 1.
   Google Scholar
• H., Zaghouani, S. A., Anderson, K. E., Sperber, C., Daian, R. C., Kennedy, L., Mayer, C. A., Bona. Induction of antibodies to the human immunodeficiency virus type1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant. Proc. Nat. Acad. Sci.. USA. 92: 631–635, 1995
   PubMed Web of Science ®Google Scholar